| View |
|
BR-289
|
Rabbit Anti-Human Thymocyte Immunoglobulin
|
Thymoglobuline
|
5 mg/mL
|
Powder for Solution for Infusion (IV)
|
-
|
Genzyme Polyclonal S.A.S.
|
France
|
Regular Renewal (Compliance)
|
30 March 2022
|
08 February 2026
|
| View |
|
BR-307
|
Hepatitis B Immunoglobulin (Human)
|
Hepabig
|
200 IU/mL
|
Solution For Injection
|
Immunoglobulin
|
Green Cross Corporation
|
Korea
|
Renewal
|
07 April 2022
|
22 March 2027
|
| View |
|
BR-324
|
Diphtheria-Tetanus Toxoids And Pertussis ( DTP ) Vaccines
|
Perdinus
|
30 IU (25 Lf) / 40 IU (5 Lf) / 4 IU per 0.5 mL
|
Suspension for Injection (IM) (Monodose)
|
-
|
Serum Institute of India Private Limited
|
India
|
-
|
26 February 2021
|
28 December 2025
|
| View |
|
BR-325
|
Diphtheria-Tetanus Toxoid ( DT )
|
Ditevac
|
30 IU/ 40 IU per 0.5 mL
|
Suspension for Injection (IM) (Pediatric-Single Dose)
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
Renewal
|
10 August 2021
|
27 September 2026
|
| View |
|
BR-326
|
Tetanus Toxoid (Adsorbed)
|
T-Vac
|
5 Lf per 0.5mL
|
Suspension for Injection (IM)
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
Automatic Renewal
|
10 August 2021
|
07 July 2026
|
| View |
|
BR-334
|
Hepabig
|
Hepatitis B Immunoglobulin (Human)
|
100 IU/0.5 mL
|
Solution For Injection
|
Immunoglobulin
|
Green Cross Corporation
|
Korea
|
Renewal
|
19 April 2022
|
06 April 2027
|
| View |
|
BR-349
|
Measles Vaccine (Live, Attenuated)
|
M-Vac
|
None
|
Lyophilized Powder for Injection (SC)
|
Vaccines
|
Serum Institute of India Pvt., Ltd.
|
India
|
Initial (Variation)
|
27 February 2024
|
27 February 2029
|
| View |
|
BR-359
|
Clostridium botulinum Type A Neurotoxin Complex
|
Botox
|
100 Units
|
Lyophilized Powder for Injection (IM)
|
-
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Regular Renewal
|
26 February 2021
|
26 September 2025
|
| View |
|
BR-388
|
Zoster Vaccine (Live)
|
V-Z Vax
|
1400 PFU/Vial
|
Lyophilized Powder For Injection (SC)
|
-
|
Green Cross Corporation
|
Korea
|
-
|
07 July 2020
|
20 June 2024
|
| View |
|
BR-404
|
Hepatitis A (inactivated) and hepatitis B (rDNA)
(HAB) vaccine (adsorbed)
|
Twinrix Adult
|
720 ELISA Units/20 mcg per mL
|
Suspension For Injection (I.M.)-Thiomersal Free
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
-
|
26 February 2021
|
19 May 2025
|
| View |
|
BR-409
|
Factor IX Complex
|
Profilnine SD
|
1000 IU/10mL
|
Iv
|
Plasma Fraction for Specific Use
|
Grifols Biologicals Inc.
|
U.S.A
|
Renewal
|
09 August 2019
|
05 October 2028
|
| View |
|
BR-411
|
Factor IX Complex
|
Profilnine SD
|
500 IU/5mL%
|
Iv
|
Plasma Fraction for Specific Use
|
Grifols Biologicals Inc.
|
U.S.A
|
Renewal
|
09 August 2019
|
16 October 2028
|
| View |
|
BR-434
|
Measles, Mumps and Rubella Vaccine (Live, Attenuated)
|
Tresivac
|
Formulation: After reconstitution, one dose (0.5 mL) contains: Measles Virus-NLT 1,000 CCID 50 Mumps Virus-NLT 5,000 CCID 50 Rubella Virus -NLT 1,000 CCID 50
|
Freeze-dried Powder for Suspension for Injection (SC)
|
-
|
Serum Institute of India Private Limited
|
India
|
Initial (Variation)
|
04 October 2022
|
04 October 2027
|
| View |
|
BR-435
|
Tetanus Toxoid ( Adsorbed )
|
T-Vac
|
5Lf per 0.5mL
|
Suspension For Injection (I.M)
|
-
|
Serum Institue of India Private Limited
|
India
|
-
|
18 March 2022
|
07 July 2026
|
| View |
|
BR-442
|
Human Albumin
|
Human Albumin 20% Behring (Low Salt)
|
0.002
|
Solution for Intravenous Infusion
|
-
|
CSL Behring GmbH
|
Germany
|
-
|
03 June 2020
|
06 January 2025
|
| View |
|
BR-451
|
Diphtheria-Tetanus Toxoids ( Adsorbed )
|
Ditevac
|
0.5mL
|
Suspension For Injection(Im) Multidose
|
-
|
Serum Institute of India Ltd.
|
India
|
-
|
08 September 2020
|
18 April 2025
|
| View |
|
BR-456
|
Sero-Tet
|
Tetanus Immune Globulin Human
|
250 IU/mL
|
Solution For Injection (IM)
|
-
|
Green Cross Corp.
|
Korea
|
-
|
14 May 2021
|
26 April 2025
|
| View |
|
BR-458
|
I.V. - Globulin SN Injection
|
Human Normal Immunoglobulin (IGIV)
|
50mg/mL (500 mg/10 mL)
|
Solution For Injection (IV)
|
-
|
Green Cross Corp.
|
Korea
|
-
|
14 May 2021
|
09 May 2025
|
| View |
|
BR-459
|
Human Albumin
|
Albumax
|
0.2
|
Solution For Injection (IV)
|
-
|
Green Cross Corp.
|
Korea
|
Renewal (Reconstruction)
|
23 May 2022
|
23 May 2025
|
| View |
|
BR-463
|
Human Albumin
|
Albutein 25% Solution
|
0.25
|
Solution for Injection for Infusion (IV)
|
-
|
Grifols Biologicals LLC
|
U.S.A
|
Renewal
|
28 April 2023
|
25 May 2027
|